AQHA Approves Surpass

The American Quarter Horse Association has Surpass, a topical non-steroidal anti-inflammatory medication. The AQHA Executive Committee approved the medication during their January meeting to keep in line with the rules of the United States Equestrian Federation Inc., which permitted therapeutic use of Surpass late last year.

Surpass (diclofenac) is a topical cream used for the contro

Share
Favorite
Close

No account yet? Register

ADVERTISEMENT

The American Quarter Horse Association has Surpass, a topical non-steroidal anti-inflammatory medication. The AQHA Executive Committee approved the medication during their January meeting to keep in line with the rules of the United States Equestrian Federation Inc., which permitted therapeutic use of Surpass late last year.

Surpass (diclofenac) is a topical cream used for the control of pain and inflammation associated with osteoarthritis in horses’ hock, knee, fetlock and pastern joints. The U.S. Food and Drug Administration-approved medication must be administered according to recommendations to ensure compliance with maximum allowable plasma levels

Create a free account with TheHorse.com to view this content.

TheHorse.com is home to thousands of free articles about horse health care. In order to access some of our exclusive free content, you must be signed into TheHorse.com.

Start your free account today!

Already have an account?
and continue reading.

Share

Written by:

Product and information releases by various organizations and companies.

Related Articles

Stay on top of the most recent Horse Health news with

FREE weekly newsletters from TheHorse.com

Sponsored Content

Weekly Poll

sponsored by:

Readers’ Most Popular

Sign In

Don’t have an account? Register for a FREE account here.

Need to update your account?

You need to be logged in to fill out this form

Create a free account with TheHorse.com!